StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) stock

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.14+0.01 (+3.82%)

Close on Nov 17, 2026Market cap $4.14MP/E –Yield –

AIM ImmunoTech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AIM ImmunoTech's price to sales ratio was 45.3× on Nov 11, 2026, against 37.5× a year earlier. Over the last 5 years it ranged from 13.3× to 376.5×, with a median of 97.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202645.3×+17.4
2025Dec 31, 202527.9×−33.2
2024Dec 31, 202461.1×−91.0
2023Dec 29, 2023152.1×+40.9
2022Dec 30, 2022111.2×−237.8
2021Dec 31, 2021349.0×−76.4
2020Dec 31, 2020425.5×+398.3
2019Apr 30, 201927.2×−21.8
2018Dec 31, 201849.0×+22.0
2017Dec 29, 201727.0×−134.3
2016Dec 30, 2016161.3×+25.6
2015Dec 31, 2015135.7×−115.3
2014Dec 31, 2014250.9×−19.9
2013Dec 31, 2013270.9×+84.6
2012Dec 31, 2012186.3×+5.6
2011Dec 30, 2011180.7×–

More AIM ImmunoTech figures

See a number that looks wrong?